Literature DB >> 32702418

Predictive factors of Boston Type I Keratoprosthesis outcomes: A long-term analysis.

Levi N Kanu1, Muanploy Niparugs1, Manachai Nonpassopon1, Faris I Karas1, Jose M de la Cruz1, Maria S Cortina2.   

Abstract

PURPOSE: To study the long-term visual- and device retention-related outcomes and complications of the Boston Type I Keratoprosthesis (KPro).
METHODS: Single-center, retrospective cohort study of all patients undergoing KPro implantation from February 2007 to April 2014 with at least 5 years of follow-up.
RESULTS: 68 eyes from 65 patients underwent KPro implantation during the study period. At 5 and 10 years, the probability of maintaining or improving visual acuity (VA) was 75.0% and 66.7%, respectively, and the probability of KPro retention was 89.2% and 89.2%, respectively. Initial device retention rate at 10 years was significantly lower in those with underlying ocular surface disease (46.8% [30.6-63.2] vs 75.8% [61.0-90.7], P = 0.03), while other baseline characteristics showed no significant association. Final VA was more likely to be stable or improved in patients with fewer failed grafts (2 [1-6] vs 3 [1-6], P < 0.01), and a final VA of 20/200 or better was more likely in primary KPro eyes (44.8% [26.7-62.9] vs 19.4% [6.5-32.3], P = 0.03). Combined KPro-vitrectomy eyes were more likely to have stable or improved final VA than non-vitrectomy eyes (88.5% [76.2-100.0] vs 64.1% [49.1-79.1], P = 0.04). All complications had increasing incidence beyond 5 years; in particular, corneal melt, surgical glaucoma interventions, and endophthalmitis tended to have late presentations, with 79.0%, 78.6%, and 88.9% of these complications occurring beyond one year, respectively.
CONCLUSIONS: KPro devices show favorable long-term visual and retention outcomes in select patients. Careful long-term, multidisciplinary follow-up is warranted to address potential complications.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Boston Type I Keratoprosthesis; KPro; Keratoprosthesis; Long-term; Outcomes

Mesh:

Year:  2020        PMID: 32702418     DOI: 10.1016/j.jtos.2020.07.012

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  3 in total

1.  Critical media attributes in E-beam sterilization of corneal tissue.

Authors:  Sina Sharifi; Hannah Sharifi; Ali Akbari; Fengyang Lei; Claes H Dohlman; Miguel Gonzalez-Andrades; Curtis Guild; Eleftherios I Paschalis; James Chodosh
Journal:  Acta Biomater       Date:  2021-10-28       Impact factor: 8.947

2.  Wide-field vitreoretinal surgery in eyes with Boston type 1 keratoprosthesis.

Authors:  Canan Asli Utine; Mahmut Kaya; Kıvanç Kasal
Journal:  Int Ophthalmol       Date:  2021-10-12       Impact factor: 2.031

3.  Toward electron-beam sterilization of a pre-assembled Boston keratoprosthesis.

Authors:  Sina Sharifi; Hannah Sharifi; Curtis Guild; Mohammad Mirazul Islam; Khoa D Tran; Corrina Patzer; Claes H Dohlman; Eleftherios I Paschalis; Miguel Gonzalez-Andrades; James Chodosh
Journal:  Ocul Surf       Date:  2021-03-03       Impact factor: 5.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.